Brouwers AH - Search Results

1

Mulders PF, Brouwers AH, Hulsbergen-van der Kaa CA, van Lin EN, Osanto S, de Mulder PH. Mulders PF, et al. Among authors: brouwers ah. Ned Tijdschr Geneeskd. 2008 Feb 16;152(7):376-80. Ned Tijdschr Geneeskd. 2008. PMID: 18380384 Review. Dutch.

2

Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.

Steffens MG, Mulders PF, Brouwers AH, Oyen WJ. Steffens MG, et al. Among authors: brouwers ah. J Urol. 2002 Nov;168(5):2127-8. doi: 10.1016/S0022-5347(05)64320-0. J Urol. 2002. PMID: 12394731 No abstract available.

3

Monoclonal antibody-based therapy for renal cell carcinoma.

Oosterwijk E, Divgi CR, Brouwers A, Boerman OC, Larson SM, Mulders P, Old LJ. Oosterwijk E, et al. Urol Clin North Am. 2003 Aug;30(3):623-31. doi: 10.1016/s0094-0143(03)00028-4. Urol Clin North Am. 2003. PMID: 12953760 Review.

4

Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.

Brouwers AH, Buijs WC, Oosterwijk E, Boerman OC, Mala C, De Mulder PH, Corstens FH, Mulders PF, Oyen WJ. Brouwers AH, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3953S-60S. Clin Cancer Res. 2003. PMID: 14506194

5

Monoclonal antibody therapy of kidney cancer.

Oosterwijk E, Brouwers A, Boerman OC, Larson SM, Old LJ, Mulders P, Divgi CR. Oosterwijk E, et al. Cancer Treat Res. 2003;116:199-212. doi: 10.1007/978-1-4615-0451-1_12. Cancer Treat Res. 2003. PMID: 14650834 Review. No abstract available.

6

Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.

Brouwers A, Mulders P, Oosterwijk E, Buijs W, Corstens F, Boerman O, Oyen W. Brouwers A, et al. Cancer Biother Radiopharm. 2004 Aug;19(4):466-77. doi: 10.1089/cbr.2004.19.466. Cancer Biother Radiopharm. 2004. PMID: 15453961

7

Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.

Brouwers AH, Mulders PF, de Mulder PH, van den Broek WJ, Buijs WC, Mala C, Joosten FB, Oosterwijk E, Boerman OC, Corstens FH, Oyen WJ. Brouwers AH, et al. J Clin Oncol. 2005 Sep 20;23(27):6540-8. doi: 10.1200/JCO.2005.07.732. J Clin Oncol. 2005. PMID: 16170161 Clinical Trial.

8

Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response.

Brouwers AH, Buijs WC, Mulders PF, de Mulder PH, van den Broek WJ, Mala C, Oosterwijk E, Boerman OC, Corstens FH, Oyen WJ. Brouwers AH, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7178s-7186s. doi: 10.1158/1078-0432.CCR-1004-0010. Clin Cancer Res. 2005. PMID: 16203819

9

Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.

Brouwers AH, Mulders PF, Oyen WJ. Brouwers AH, et al. J Clin Oncol. 2008 Aug 1;26(22):3808-9; author reply 3811-2. doi: 10.1200/JCO.2008.17.6073. J Clin Oncol. 2008. PMID: 18669472 No abstract available.

10

[Medullary thyroid cancer, a tumour with many appearances].

Verbeek HH, de Groot JW, Plukker JT, Hofstra RW, Brouwers AH, Kerstens MN, Links TP. Verbeek HH, et al. Among authors: brouwers ah. Ned Tijdschr Geneeskd. 2010;154:A1818. Ned Tijdschr Geneeskd. 2010. PMID: 20858319 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters